- Home
- HPH vs GUTS Comparison
HPH vs GUTS Comparison
Compare HPH & GUTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HPH
- GUTS
- Stock Information
- Founded
- HPH 2010
- GUTS 2010
- Country
- HPH China
- GUTS United States
- Employees
- HPH N/A
- GUTS N/A
- Industry
- HPH
- GUTS
- Sector
- HPH
- GUTS
- Exchange
- HPH NYSE
- GUTS NYSE
- Market Cap
- HPH 137.1M
- GUTS 110.1M
- IPO Year
- HPH 2019
- GUTS 2024
- Fundamental
- Price
- HPH $0.27
- GUTS $2.08
- Analyst Decision
- HPH
- GUTS Buy
- Analyst Count
- HPH 0
- GUTS 2
- Target Price
- HPH N/A
- GUTS $18.00
- AVG Volume (30 Days)
- HPH 86.6K
- GUTS 275.0K
- Earning Date
- HPH 01-01-0001
- GUTS 02-02-2025
- Dividend Yield
- HPH N/A
- GUTS N/A
- EPS Growth
- HPH N/A
- GUTS N/A
- EPS
- HPH N/A
- GUTS N/A
- Revenue
- HPH $286,996,105.00
- GUTS $97,000.00
- Revenue This Year
- HPH N/A
- GUTS N/A
- Revenue Next Year
- HPH N/A
- GUTS N/A
- P/E Ratio
- HPH N/A
- GUTS N/A
- Revenue Growth
- HPH 1722.42
- GUTS N/A
- 52 Week Low
- HPH $0.26
- GUTS $1.74
- 52 Week High
- HPH $10.06
- GUTS $14.50
- Technical
- Relative Strength Index (RSI)
- HPH 28.85
- GUTS 43.94
- Support Level
- HPH $0.26
- GUTS $1.99
- Resistance Level
- HPH $0.29
- GUTS $2.58
- Average True Range (ATR)
- HPH 0.02
- GUTS 0.19
- MACD
- HPH 0.01
- GUTS -0.02
- Stochastic Oscillator
- HPH 5.00
- GUTS 13.01
About HPH HIGHEST PERFORMANCE HLDGS INC
Highest Performances Holdings Inc is a financial technology service group based on family financial asset allocation. It focuses on providing personalized wealth management services for emerging middle-class and affluent families, comprehensive support services for financial planners, and diversified financial services for institutional clients.
About GUTS FRACTYL HEALTH INC
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.